Showing 1 - 3 results of 3 for search 'Clara González-Santillana', query time: 0.03s Refine Results
  1. 1
    Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients

    Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy Recipients by José Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, Irene García-Cadenas, Lourdes Vazquez, Javier Lopez-Jimenez, Pedro Chorão, Cristina Aroca, Carolina García-Vidal, Ignacio Arroyo, Eva Soler-Espejo, Lucia López-Corral, Alejandro Avendaño-Pita, Anna Arrufat, Valentín Garcia-Gutierrez, Elena Arellano, Lorena Hernández-Medina, Clara González-Santillana, Julia Morell, José Ángel Hernández-Rivas, Paula Rodriguez-Galvez, Mireia Mico-Cerdá, Manuel Guerreiro, Diana Campos, David Navarro, Ángel Cedillo, Rodrigo Martino, Carlos Solano

    Published 2023-10-01
    Get full text
    Article
  2. 2
    One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

    One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients by José Luis Piñana, Lourdes Vazquez, Marisa Calabuig, Lucia López-Corral, Gabriel Martin-Martin, Lucia Villalon, Gabriela Sanz-Linares, Venancio Conesa-Garcia, Andrés Sanchez-Salinas, Beatriz Gago, Ana Facal, Irene Risco-Gálvez, María T. Olave, Ildefonso Espigado, Javier Lopez-Jimenez, José Ángel Hernández-Rivas, Alejandro Avendaño-Pita, Ignacio Arroyo, Elena Ferrer, Irene García-Cadenas, Clara González-Santillana, Alicia Roldán-Pérez, Blanca Ferrer, Manuel Guerreiro, María Suarez-Lledó, Angela Camara, Diana Campos-Beltrán, David Navarro, Ángel Cedillo, Anna Sureda, Carlos Solano, Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH-TC), Rodrigo Martino

    Published 2023-01-01
    Get full text
    Article
  3. 3
    Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy

    Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapy by José Luis Piñana, José Luis Piñana, Lourdes Vazquez, Inmaculada Heras, Tommaso Francesco Aiello, Lucia López-Corral, Ignacio Arroyo, Ignacio Arroyo, Eva Soler-Espejo, Irene García-Cadenas, Valentín Garcia-Gutierrez, Cristina Aroca, Pedro Chorao, María T. Olave, Javier Lopez-Jimenez, Marina Acera Gómez, Elena Arellano, Marian Cuesta-Casas, Alejandro Avendaño-Pita, Clara González-Santillana, José Ángel Hernández-Rivas, Alicia Roldán-Pérez, Mireia Mico-Cerdá, Mireia Mico-Cerdá, Manuel Guerreiro, Julia Morell, Julia Morell, Paula Rodriguez-Galvez, Paula Rodriguez-Galvez, Jorge Labrador, Diana Campos, Diana Campos, Diana Campos, Ángel Cedillo, Carolina Garcia Vidal, Rodrigo Martino, Carlos Solano, Carlos Solano, Carlos Solano

    Published 2024-06-01
    Get full text
    Article

Search Tools: